HERCEPTIN 600 MG/ 5 ML S.C.

Показания к применению

Метастазирующий рак молочной железы с опухолевой гиперэкспрессией HER2 (монотерапия после одной или более схем химиотерапии, в комбинации с паклитакселом в случае отсутствия предшествующей химиотерапии).

Действующее вещество:

TRASTUZUMAB

Описание препарата на английском

Breast cancerMetastatic breast cancerHerceptin is indicated for the treatment of adult patients with HER2 positive metastatic breast cancer (MBC): - as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. Hormone receptor positive patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments. - in combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable. - in combination with docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. - in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive MBC, not previously treated with trastuzumab.Early breast cancerHerceptin is indicated for the treatment of adult patients with HER2 positive early breast cancer (EBC). - following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable) . - following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel. - in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin. - in combination with neoadjuvant chemotherapy followed by adjuvant Herceptin therapy, for locally advanced (including inflammatory) disease or tumours > 2 cm in diameterHerceptin should only be used in patients with metastatic or early breast cancer whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay .

Характеристики
По рецепту по рецепту
Срок годности 18 мес.
Форма употребления SOLUTION FOR INJECTION

Ссылка на сайт МинЗдрава Израиля: http://www.old.health.gov.il/units/pharmacy/trufot/PerutTrufa.asp?Reg_Number=154 80 34547 00&safa=e


Оставить отзыв

Примечание: HTML разметка не поддерживается! Используйте обычный текст.
    Плохо           Хорошо

Герцептин

HERCEPTIN 600 MG/ 5 ML S.C. Герцептин - инструкция по применению

    Рекомендуемая цена в аптеках Израиля

Фасовка Цена
1 X VIAL 207309 р.

* Аптечные цены установлены Министерством здравоохранения Государства Израиль

TRASTUZUMAB